Drug intelligence / Profile preview

Xuebijing + carbapenem

Development stage
Unknown
Lead developer
Tianjin Chase Sun Pharmaceutical
Modality
Small Molecules
Administration
Intravenous
01

Overview

Xuebijing + carbapenem is a combination therapy consisting of Xuebijing, a traditional Chinese medicine injection, and a carbapenem-class antibiotic. Xuebijing is composed of extracts from five medicinal herbs and is approved in China for the treatment of sepsis. It exhibits antibacterial, antioxidative, and anti-endotoxin properties. Its mechanisms include inhibition of pro-inflammatory cytokines (such as TNF-α and IL-6), improvement in blood rheology, enhancement of vascular tone, reduction in vascular permeability, and repair of endothelial cell gaps[1][2]. Carbapenems are broad-spectrum beta-lactam antibiotics that inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins; they are used to treat severe or high-risk bacterial infections including those caused by multidrug-resistant organisms[3]. The combination aims to leverage the immunomodulatory effects of Xuebijing with the potent antibacterial activity of carbapenems for synergistic efficacy against severe infections such as sepsis.

Other names
carbapenem + Xuebijing injection
02

Targets

JAK2 (Janus kinase 2)STAT3 (Signal Transducer and Activator of Transcription 3)MMP9 (Matrix metalloproteinase-9)TLR4 (Toll-like receptor 4)PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Xuebijing + carbapenem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xuebijing + carbapenem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call